Historical record - last NADAC effective date: 5/18/2022
Product Information
NYSTATIN 100,000 UNIT/GM OINT is a generic product labeled by Leading Pharma, LLC, priced at $0.3345 per GM under NDC 69315030715. Its NADAC has been published 133 times since Nov 20, 2019.
FDA first approved this application on May 21, 2018. Its Orange Book therapeutic-equivalence code is AT.
Strength
100000 [USP'U]/g
Manufacturer
Leading Pharma, LLCNDC
69315030715
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
5/18/2022
Active Ingredients
NYSTATINApproval Type
Generic (ANDA)
FDA Application
ANDA209082FDA Approved
5/21/2018
TE Code
AT
On Market Since
8/19/2019
Pharmacological Classes
Price Statistics
The NADAC for NYSTATIN 100,000 UNIT/GM OINT has been published 133 times since Nov 20, 2019, and over the history we have for it it has declined 30.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3345 per GM |
|---|---|
| All-time high | $0.5527 (Oct 14, 2020) |
| All-time low | $0.3146 (Sep 22, 2021) |
| Median price | $0.4205 |
| Average price | $0.4129 |
| Largest weekly change | +33.7% (Oct 20, 2021) |
| Weeks tracked | 133 |
| Tracking since | Nov 20, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
+6.3%
All
-30.0%
Last surveyed Jun 1, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the NYSTATIN market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Leading Pharma, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
NYSTATIN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Polyene Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NYSTATIN 100,000 UNIT/GM OINT?
The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN 100,000 UNIT/GM OINT, manufactured by Leading Pharma, LLC, is $0.3345 per GM (NDC 69315030715), effective Jun 1, 2022.
How has the price of NYSTATIN 100,000 UNIT/GM OINT changed over time?
Over the history we have for it, the NADAC for NYSTATIN 100,000 UNIT/GM OINT has declined 30.0%. It has been tracked across 133 weekly CMS publications since Nov 20, 2019.
What are the highest and lowest recorded NADAC prices for NYSTATIN 100,000 UNIT/GM OINT?
Since Nov 20, 2019, the NADAC for NYSTATIN 100,000 UNIT/GM OINT has ranged from a low of $0.3146 (Sep 22, 2021) to a high of $0.5527 (Oct 14, 2020), with a median of $0.4205 per GM.
Are there cheaper alternatives to NYSTATIN 100,000 UNIT/GM OINT?
No other NADAC-published product currently shares the active ingredient and strength of NYSTATIN 100,000 UNIT/GM OINT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NYSTATIN 100,000 UNIT/GM OINT?
NYSTATIN 100,000 UNIT/GM OINT (NDC 69315030715) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.